Research Article

RNA-Seq Expression Analysis of Chronic Asthmatic Mice with Bu-Shen-Yi-Qi Formula Treatment and Prediction of Regulated Gene Targets of Anti-Airway Remodeling

Table 1

Differently expressed genes showing the highest fold changes (in either direction) in lung samples of the mice in the control (C), asthmatic model (M), and BSYQF treatment (T) groups.

A. M vs CB. T vs MC
GeneFold changeGeneFold changeGeneM vs CT vs M

IncreasedIncreasedTimp16.22−3.01
Chil411.74A530016L24Rik7.79Reg16.20−3.30
Sprr2a311.18Tmem1797.17Dmp15.65−4.15
Clca19.86Serpinb117.01Glod55.55−5.52
Mcpt18.71Ebf26.85Rnf175.35−5.33
Rnase2a8.43Htr3a6.59Dspp5.14−5.11
Capn97.48Lep6.52Lep−8.646.52
Saa37.42Glycam16.43A530016L24Rik−8.367.79
Saa17.23Syt46.39Tmem179−7.577.17
Saa47.18Lrtm15.95Lctl−7.365.20
Retnlb7.09Nalcn5.91Ebf2−6.776.85
A6.93Slc5a85.89Nalcn−6.425.91
Cd209e6.93Dsc35.84Adipoq−5.975.80
Mmp126.84Adipoq5.80Htr3a−5.586.59
Timd26.78Lsmem15.76Myh1−5.574.94
Retnla6.64Ugt2b345.57Car3−5.505.10
Cbln16.47Cartpt5.54Gm10382−5.404.72
Mrgprg6.32Dnmt3c5.51Lrtm1−5.395.95
Prss326.27Nefm5.46Slc5a8−5.295.89
Timp16.22Slc38a35.42Hist1h4k−5.275.29
Reg16.20Pnoc5.39Kcnq3−5.265.22
Fgl16.18Hist1h4k5.29Pnoc−5.185.39
Btbd166.12Krt6a5.26Dnmt3c−5.165.51
Nuggc6.11Serpina1e5.24Retn−5.094.96
DecreasedAcp75.24Cfd−5.065.01
Lep−8.64Krt55.23Lsmem1−5.035.76
A530016L24Rik−8.36Kcnq35.22
Tmem179−7.57BC1170905.21
Lctl−7.36Lctl5.20
Ebf2−6.77BC0165795.19
Gys2−6.69Car35.10
Ebf3−6.58Gm54165.09
Nalcn−6.42Dync1i15.03
Cfd5.01
Decreased
Glod5−5.52
Rnf17−5.33
Dspp−5.11
Gm49320−5.03
Azgp1−5.03

A, all genes with increased or decreased expression levels by FC > (±)6 () in the asthma group (M) relative to the control group (C); B, all genes upregulated or downregulated by the BSYQF treatment group (T) with FC > =(±)5 () relative to the asthma group (M). C, all genes with FC > (±)5 () that were reverted in their expression towards normal levels by BSYQF treatment. Genes are ranked orderly by FC (positive or negative values).